Hybrid nanofibril matrices for use as tissue engineering devices
US6689166B2 · kind B2 · utility
78Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2002 |
| Grant date | Feb 10, 2004 |
| Priority date | — |
| Expiry date | Oct 8, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/914
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Tissue engineering devices with enhanced cell adhesion, cell proliferation and directional growth are provided which are prepared from nonwoven nanofibril matrices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.